期刊文献+

自然成熟型树突状细胞对CD4^+CD25^+调节性T细胞扩增的影响 被引量:1

Impact of CD4^+CD25^+ regulatory T cells expanded by natural mature dendritic cells
下载PDF
导出
摘要 目的:探讨自然成熟型树突状细胞对CD4+CD25+调节性T细胞扩增机制。方法:提取DAB/2小鼠脾脏及肝脏细胞,流式细胞仪分离树突状细胞,测定其纯度及表型,加入C3H/HeJ小鼠提取的CD4+CD25+调节性T细胞混合培养,测定其增殖活性。利用CD4+CD25-T细胞测定扩增后的CD4+CD25+调节性T细胞的免疫抑制活性。结果:成熟型树突状细胞表达高水平的共刺激分子CD40、CD80及CD86,对CD4+CD25+调节性T细胞扩增效果明显。与新鲜分离的CD4+CD25+调节性T细胞一样,扩增的CD4+CD25+调节性T细胞高表达Foxp3,而且均保持了其抑制活性。结论:自然成熟型树突状细胞能扩增CD4+CD25+调节性T细胞,且扩增后的调节性T细胞保持了其表达活性和抑制活性。 Objective: To investigate the impact of CD4^+CD25^+ regulatory T cells expanded by natural mature dendritic cells. Methods: The dendritic cells were isolated from DAB/2 mice spleens and livers using fluorescenceactivated cell sorter. The purity and surface phenotype of DCs was analyzed, The freshly isolated C3H/HeJ CD4^+CD25^+ T cells were cultured with DCs. Poliferative responses were measured by [^3H] thymidine incorporation and expression of Foxp3. The suppressive activity CD4^+CD25^+ T cells were examine by CD4^+CD25- T cells. Results:Natural mature dendritic cells expressed higher CD40, CD80, CD86, and promoted the expansion of CD4^+CD25^+ regulatory T cells. The CD4^+CD25^+ T cells expanded by mature DCs maintained their expression of Foxp3 and suppressed the proliferation of CD4^+CD25^+ T cells similar to freshly isolated CD4^+CD25^+ T cells. Conclusion: Natural mature DCs expanded CD4^+CD25^+ Treg cells and preserved its function.
出处 《中国现代普通外科进展》 CAS 2014年第1期12-16,共5页 Chinese Journal of Current Advances in General Surgery
关键词 CD4^+CD25^+ 调节性T细胞 树突状细胞 细胞扩增 CD4^+CD25^+ regulatory T cells Dendritic cells Expansion
  • 相关文献

参考文献11

  • 1Sakaguchi S, Ono M, Setoguehi R, et al. Foxp3^+ CD4^+CD25^+ natural regulatory T cells in dominant self-tolermwe and autoimmune dis- ease[J], lmmunol Rev, 2006, 212: 8-27.
  • 2Dinh TN, Kyaw TS, Kanellakis P, et al. Cytokine therapy with in- terleukin-2/anti-interleukin-2 monoehmal antibody complexes ex- pandsCD4^+CD25^+ Foxp3^+ regulatory T cells and attenuates dewqop- ment and progression of atheroselensis [J]. Circulation, 2012.126 (10): 1256-1266.
  • 3Malek TR, Yu A, Vincek V. el al. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. hnplieations lor the nonre- dundant function of 1L-2[J]. Immunity, 2002,17(2):167-178.
  • 4Ellis JS, Wan X, Braley H. Transient depletion of CD4^+CD25^+ regu- latory T cells results in muhiple autoimmune diseases in WT and B cell deficient NOD mice[J]. 1 mmunoluogy, 2013,139 ( 2 ): 179-186.
  • 5Coquet JM, Ribot JC, Babala N, et al. Epithelial and dendritic cells in the thymie medulla promote CD4^+Foxp3^+ regulatoD' T cell devel- opment via the CD27-CD70 pathway [J]. J Exp Med, 2013,210 (4):715-728.
  • 6Nakai N, Katoh N, Kitagawa T, et al. hnmunoregulatogy T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocvte-derived dendritic cell vaeeination [J]. J Demmtol Sei, 2009,54:31-37.
  • 7Fehervari Z, Sakaguehi S. Control of Foxp3^+ CD25^+CD4^+ regulatou' cell aetivation and fimction by dendritic cells [J]. Int lnmumul, 2004,16( 12):1769-1780.
  • 8Costa-Carvalho BT. de Moraes-Pinto M1, de Almeida LC, et al. A remarkable depletion of both naive CD4^+ and CD8^+ with high pro- portion of memory T cells in an IPEX infant with a FOXP3 muta- tion in the forkhead domain[J]. Scand J lmmunol, 2008,68:85-91.
  • 9Tsai BY, Suen JL. Chiang BL. Lentiviral-mediated Foxp3 RNAi suppresses tumor growth of regulatory T cell-like leukemia in a murine tumor model[J]. Gene Ther, 2010,17 (8) :972-979.
  • 10Takano T, Hosoya S. Shibao A, et al. Comparative study of the plasma globulin level, CD21 (-) B-cell counts and FOXP3 mRNA expression level in CD4(+) T-cells for different clinical stages of feline immunodeficiency virus infected cats[J]. Res Vet Sci, 2012, 92:157-161.

同被引文献19

  • 1Kim H, Kataru RP, Koh GY. Regulation and implications of inflammatory lymphangiogenesis [ J ]. Trends Immunol, 2012,33(7) :350-356.
  • 2Sheng KC, Wright MD, Apostolopoulos V. Inflammatory mediators hold the key to dendritie eell suppression and tumor progression [J]. Curt Med Chem,2011 ,18(36) :5507-5518.
  • 3Whiteside TI. Antitum or vaccines in head and neck cancer: targeting immune responses to the tumor [ J ]. Curt Cancer Drug Targets, 2007,7 ( 7 ) : 633-642.
  • 4Pinzon-Chatty A, Maxwell Lopez JA. Dendritic cell dysfunction in cancer: a mechanism for immunosuppression [ J ]. Immunol Cell Biol,2005,83 (5) :451-461.
  • 5Malhot L, Stenninger J. Behavior of seeds and soil in the mechanism of metastasis:a deeper understanding[ J ]. Cancer Sci, 2012,103 (4) :626-631.
  • 6Jemal A, Bray F,center MM,et al. Global cancer statistics[ J]. CA Cancer J Clin,2011,61 (2) :69-90.
  • 7Tie J, Desai J. Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system [ J ]. Crit Rev Oncog, 2012,17( 1 ) :51-67.
  • 8Eichmann A, Simons M. VEGF signaling inside vascular endothelial cells and beyond [ J ]. Curr Opin Cell Biol, 2012,24 (2) :188-193.
  • 9Delirezh N, Moazzeni SM, Shokri F, et al. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell mediated immune responses against breast cancer in vitro [ J ]. Cell Immuno1,2009,257 ( 1/2 ) :23-31.
  • 10Fujii S, Takayama T, Asakura M, et al. Dendritic cell based cancer immunotherapies [ J ]. Arch Immunol Ther Exp, 2009,57 (3) :189-198.

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部